about
Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approve...
Read More
15.48
0.35
(2.31%)
165.7K
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Mesoblast Ltd (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..